secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2022-09-23T23:59:59+00:00
Accession:  0001437749-22-022980
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx shareholders approve reverse stock split of 1-for-10 to 1-for-30
-----------------------------------------------------------------------

- Special meeting held Sep 23, 2022; proposal to authorize board to effect reverse split passed.
- Common shares: 53,371,108 for, 25,270,193 against; plus Series A Preferred votes included proportionally.
- Board authorized to implement split at ratio from 1:10 to 1:30 within one year.
- No broker non-votes; proposal was approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922022980/0001437749-22-022980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774922022980/acrx20220923_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-022980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer